Crossmark

pH-sensitive nanoformulation of acetyl-11-keto-beta-boswellic acid (AKBA) as a potential antiproliferative agent in colon adenocarcinoma (in vitro and in vivo)

Crossref DOI link: https://doi.org/10.1186/s12645-024-00289-9

Published Online: 2024-09-06

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ale-Ahmad, Atiyeh

Kazemi, Sohrab

Daraei, Abdolreza

Sepidarkish, Mahdi

Moghadamnia, Ali Akbar

Parsian, Hadi
Funding

Funding for this research was provided by:

Babol University of Medical Sciences

Iran National Science Foundation

Biotechnology Development Council of the Islamic Republic of Iran
License Information

Text and Data Mining valid from 2024-09-06

Version of Record valid from 2024-09-06
More Information

Article History

Received: 7 May 2024

Accepted: 28 August 2024

First Online: 6 September 2024

Declarations

:

: Babol University of Medical Sciences' Research Ethics Committees approved and reviewed the experimental protocol with the approval ID IR.MUBABOL.REC.1400.264.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below